JSEPX
Price
$35.04
Change
+$0.18 (+0.52%)
Updated
Jul 31 closing price
Net Assets
2.68B
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

JSEPX vs VSMAX

JSEPX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
JSEPX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSEPX is a Hold and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. JSEPX (2.68B). VSMAX pays higher dividends than JSEPX: VSMAX (1.21) vs JSEPX (0.00). JSEPX was incepted earlier than VSMAX: JSEPX (10 years) vs VSMAX (26 years). JSEPX (1.24) is less costly to investors than VSMAX (0.05). JSEPX is a more actively managed with annual turnover of: 52.00 vs. VSMAX (17.00). JSEPX has a lower initial minimum investment than VSMAX: JSEPX (0) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 22.58 vs. JSEPX (-12.86). VSMAX return over 5 years is better than : 35.11 vs. JSEPX (-45.59).
JSEPXVSMAXJSEPX / VSMAX
Total Expense Ratio1.240.052,480%
Annual Report Gross Expense Ratio1.240.052,480%
Fund Existence10 years26 years-
Gain YTD10.36214.58871%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.68B189B1%
Annual Yield % from dividends0.001.21-
Returns for 1 year-12.8622.58-57%
Returns for 3 years-17.6443.42-41%
Returns for 5 years-45.5935.11-130%
Returns for 10 yearsN/A155.96-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H